Postoperative relative decrease in skeletal muscle mass as a predictor of quality of life in patients with gastric cancer

Ueda,Yoshinori; Seshimo,Akiyoshi; Okamoto,Takahiro

doi:10.3892/mco.2023.2655

Postoperative relative decrease in skeletal muscle mass as a predictor of quality of life in patients with gastric cancer

Authors:
- Yoshinori Ueda
- Akiyoshi Seshimo
- Takahiro Okamoto
View Affiliations

Affiliations: Department of Surgery II, Tokyo Women's Medical University, Tokyo 162‑8666, Japan, Department of Digestive Surgery, Ushiku Aiwa General Hospital, Ushiku, Ibaraki 300‑1296, Japan
Published online on: June 21, 2023 https://doi.org/10.3892/mco.2023.2655
Article Number: 59
Copyright: © Ueda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Low skeletal muscle mass reflects poor nutritional condition, which may impair the functional status and quality of life (QOL) of survivors of gastrectomy. The present cross‑sectional study examined the association between a relative change in skeletal muscle mass and perceived postoperative health and QOL in patients with gastric cancer. The study comprised 74 patients (48 men and 26 women; median age, 68.5 years) who underwent surgery for stage I‑III gastric cancer. Outcomes were measured using the Postgastrectomy Syndrome Assessment Scale‑45, which was specifically developed to measure post‑gastrectomy symptoms, living status, dissatisfaction with daily life and generic QOL. The skeletal muscle mass index (SMI) was estimated using computed tomography by tracing the area of the psoas major muscle to calculate the ΔSMI, defined as: (SMI before surgery‑SMI at completion of the PGSAS‑45 survey)/SMI before surgery x100. Associations between ΔSMI and health outcomes were assessed using univariate and multivariate analyses. The mean ΔSMI (SD) was 8.64% (10.6%). The effect size (Cohen's d) of ΔSMI <10% compared with ΔSMI ≥10% was 0.50 (95% CI: 0.02 to 0.97) for total symptom scores, ‑0.51 (‑0.98 to ‑0.03) for general health, and ‑0.52 (‑0.99 to ‑0.05) for the physical component summary (PCS). Multiple regression analysis showed that ΔSMI was significantly associated with PCS decline, and its standardized regression coefficient was ‑0.447 (‑0.209 to ‑0.685). Determining ΔSMI may help clinicians to facilitate the objective evaluation of low skeletal mass, which reflects poor nutritional condition that can impair functional status and QOL of postoperative patients surviving gastrectomy.

View Figures

View References

1	Foundation for Promotion of Cancer Research: Cancer statistics in Japan 2019. https://ganjoho.jp/data/reg_stat/statistics/brochure/2019/cancer_statistics_2019.pdf. Accessed May 29, 2020 (In Japanese).
2	Thybusch-Bernhardt A, Schmidt C, Küchler T, Schmid A, Henne-Bruns D and Kremer B: Quality of life following radical surgical treatment of gastric carcinoma. World J Surg. 23:503–508. 1999.PubMed/NCBI View Article : Google Scholar
3	Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G and Nakao A: Assessment of quality of life after gastrectomy using EORTC QOL-C30 and STO22. World J Surg. 35:357–364. 2011.PubMed/NCBI View Article : Google Scholar
4	Lim HS, Cho GS, Park YH and Kim SK: Comparison of quality of life and nutritional status in gastric cancer patients undergoing gastrectomies. Clin Nutr Res. 4:153–159. 2015.PubMed/NCBI View Article : Google Scholar
5	Carey S, Storey D, Biankin AV, Martin D, Young J and Farinelli MA: Long-term nutritional status and quality of life following major upper gastrointestinal surgery-a cross-sectional study. Clin Nutr. 30:774–779. 2011.PubMed/NCBI View Article : Google Scholar
6	Climent M, Munarriz M, Blazeby JM, Dorcaratto D, Ramon JM, Carrera MJ, Fontane L, Grande L and Pera M: Weight loss and quality of life in patients surviving 2 years after gastric cancer resection. Eur J Surg Oncol. 43:1337–1343. 2017.PubMed/NCBI View Article : Google Scholar
7	Huang DD, Ji YB, Zhou DL, Li B, Wang SL, Chen XL, Yu Z and Zhuang CL: Effect of surgery-induced acute muscle wasting on postoperative outcomes and quality of life. J Surg Res. 218:58–66. 2017.PubMed/NCBI View Article : Google Scholar
8	Luu C, Arrington AK, Falor A and Kim J, Lee B, Nelson R, Singh G and Kim J: Impact of gastric cancer resection on body mass index. Ann Surg. 80:1022–1025. 2014.PubMed/NCBI
9	Yaguchi Y, Kumata Y, Horikawa M, Kiyokawa T, Iinuma H, Inaba T and Fukushima R: Clinical significance of area of psoas major muscle on computed tomography after gastrectomy in gastric cancer patients. Ann Nutr Metab. 71:145–149. 2017.PubMed/NCBI View Article : Google Scholar
10	Guyatt GH, Feeny DH and Patrick DL: Measuring health-related quality of life. Ann Intern Med. 118:622–629. 1993.PubMed/NCBI View Article : Google Scholar
11	Gill TM and Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA. 272:619–626. 1994.PubMed/NCBI
12	Karimi M and Brazier J: Health, health-related quality of life, and quality of life: What is the difference? Pharmacoeconomics. 34:645–649. 2016.PubMed/NCBI View Article : Google Scholar
13	Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y, Kawashima Y, Oshio A, Suzukamo Y, Terashima M and Kodera Y: Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: Newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer. 18:147–158. 2015.PubMed/NCBI View Article : Google Scholar
14	Fukuhara S and Suzukamo Y: Manual of the SF-8 Japanese version. Institute for Health Outcomes and Process Evaluation Research, Kyoto, pp13-24, 46-72, 2004 (In Japanese).
15	Svedlund J, Sjödin I and Dotevall G: GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 33:129–134. 1988.PubMed/NCBI View Article : Google Scholar
16	Saito M, Seshimo A, Miyake K, Yamaguchi R and Okamoto T: Efficiency of bioelectric impedance analysis as an evaluation method of skeletal muscle mass after gastrectomy. Int Surg. 102:422–426. 2017.
17	Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Hammad A, Tamai Y, Inagaki N and Uemoto S: Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults. Nutrition. 32:1200–1205. 2016.PubMed/NCBI View Article : Google Scholar
18	Ellis PD: The essential guide to effect sizes: Statistical power, meta-analysis, and the interpretation of research results. Cambridge University Press, Cambridge, pp3-30, 2010.
19	Kleinbaum DG: Logistic Regression: A Self-Learning Text. Springer-Verlag, New York, NY, pp161-226, 1994.
20	Kleinbaum DG, Kupper LL and Muller KE: Applied Regression Analysis and Other Multivariable Methods. 2nd edition. Duxbury Press, Belmont, CA, pp124-143, 1988.
21	The jamovi project, jamovi version 1.6 [Computer Software]. https://www.jamovi.org. Accessed September 26, 2021.
22	Elkinton JR: Medicine and quality of life. Ann Intern Med. 64:711–714. 1966.PubMed/NCBI View Article : Google Scholar
23	Haraldstad K, Wahl A, Andenaes R, Andersen JR, Andersen MH, Beisland E, Borge CR, Engebretsen E, Eisemann M, Halvorsrud L, et al: A systematic review of quality of life research in medicine and health sciences. Qual Life Res. 28:2641–2650. 2019.PubMed/NCBI View Article : Google Scholar
24	Feinstein AR: Clinimetric perspectives. J Chronic Dis. 40:635–640. 1987.PubMed/NCBI View Article : Google Scholar
25	Lara-Muñoz C and Feinstein AR: How should quality of life be measured? J Investig Med. 47:17–24. 1999.PubMed/NCBI
26	Leplège A and Hunt S: The problem of quality of life in medicine. JAMA. 278:47–50. 1997.PubMed/NCBI View Article : Google Scholar
27	Wu JT and Kral JG: Ghrelin: Integrative neuroendocrine peptide in health and disease. Ann Surg. 239:464–474. 2004.PubMed/NCBI View Article : Google Scholar
28	De Vriese C and Delporte C: Ghrelin: A new peptide regulating growth hormone release and food intake. Int J Biochem Cell Biol. 40:1420–1424. 2008.PubMed/NCBI View Article : Google Scholar
29	Kizaki J, Aoyagi K, Sato T, Kojima M and Shirouzu K: Production of ghrelin by the stomach of patients with gastric cancer. Kurume Med J. 60:99–104. 2013.PubMed/NCBI View Article : Google Scholar
30	Tuero C, Valenti V, Rotellar F, Landecho MF, Cienfuegos JA and Fruhbeck G: Revisiting the ghrelin changes following bariatric and metabolic surgery. Obes Surg. 30:2763–2780. 2020.PubMed/NCBI View Article : Google Scholar
31	Seo MH, Kim MK, Park SE, Rhee EJ, Park CY, Lee WY, Baek KH, Song KH, Kang MI and Oh KW: The association between daily calcium intake and sarcopenia in older, non-obese Korean adults: The fourth Korea National Health and Nutrition Examination Survey (KNHANES IV) 2009. Endocr J. 60:679–686. 2013.PubMed/NCBI View Article : Google Scholar
32	Kunisaki C, Yoshida K, Yoshida M, Matsumoto S, Arigami T, Sugiyama Y, Seto Y, Akiyama Y, Oshio A and Nakada K: Effects of proximal gastrectomy and various clinical factors on postoperative quality of life for upper-third gastric cancer assessed using the Postgastrectomy Syndrome Assessment Scale-45 (PGSAS-45): A PGSAS NEXT Study. Ann Surg Oncol. 29:3899–3908. 2022.PubMed/NCBI View Article : Google Scholar
33	Rupp SK and Stengel A: Influencing factors and effects of treatment on quality of life in patients with gastric cancer-A systematic review. Front Psychiatry. 12(656929)2021.PubMed/NCBI View Article : Google Scholar
34	Pennacchini M, Bertolaso M, Elvira MM and De Marinis MG: A brief history of the quality of life: Its use in medicine and in philosophy. Clin Ter. 162:e99–e103. 2011.PubMed/NCBI
35	McClimans L and Browne JP: Quality of life is a process not an outcome. Theor Med Bioeth. 33:279–292. 2012.PubMed/NCBI View Article : Google Scholar
36	Moons P, Van Deyk K, De Bleser L, Marquet K, Raes E, De Geest S and Budts W: Quality of life and health status in adults with congenital heart disease: A direct comparison with healthy counterparts. Eur J Cardiovasc Prev Rehabil. 13:407–413. 2006.PubMed/NCBI View Article : Google Scholar
37	Wang SL, Zhuang CL, Huang DD, Pang WY, Lou N, Chen FF, Zhou GJ, Shen X and Yu Z: Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: A prospective study. Ann Surg Oncol. 23:556–564. 2016.PubMed/NCBI View Article : Google Scholar
38	Sakurai K, Kubo N, Tamura T, Toyokawa T, Amano R, Tanaka H, Muguruma K, Yashiro M, Maeda K, Hirakawa K and Ohira M: Adverse effects of low preoperative skeletal muscle mass in patients undergoing gastrectomy for gastric cancer. Ann Surg Oncol. 24:2712–2719. 2017.PubMed/NCBI View Article : Google Scholar
39	Yamaoka Y, Fujitani K, Tsujinaka T, Yamamoto K, Hirao M and Sekimoto M: Skeletal muscle loss after total gastrectomy, exacerbated by adjuvant chemotherapy. Gastric Cancer. 18:382–389. 2015.PubMed/NCBI View Article : Google Scholar
40	Lis CG, Gupta D, Lammersfeld CA, Markman M and Vashi PG: Role of nutritional status in predicting quality of life outcomes in cancer: A systematic review of the epidemiological literature. Nutr J. 11(27)2012.PubMed/NCBI View Article : Google Scholar
41	Gielen E, Beckwee D, Delaere A, De Breucker S, Vandewoude M and Bautmans I: Sarcopenia Guidelines Development Group of the Belgian Society of Gerontology and Geriatrics (BSGG). Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: An umbrella review of systematic reviews and meta-analyses. Nutr Rev. 79:121–147. 2021.PubMed/NCBI View Article : Google Scholar
42	Singh B, Hayes SC, Spence RR, Steele ML, Millet GY and Gergele L: Exercise and colorectal cancer: A systematic review and meta-analysis of exercise safety, feasibility and effectiveness. Int J Behav Nutr Physic Act. 17(122)2020.PubMed/NCBI View Article : Google Scholar
43	Beckwee D, Delaere A, Aelbrecht S, Baert V, Beaudart C, Bruyere O, de Saint-Hubert M and Bautmans I: Exercise interventions for the prevention and treatment of sarcopenia. A systematic umbrella review. J Nutr Health Aging. 23:494–502. 2019.PubMed/NCBI View Article : Google Scholar
44	Kim AR, Cho J, Hsu YJ, Choi MG, Noh JH, Sohn TS, Bae JM, Yun YH and Kim S: Changes of quality of life in gastric cancer patients after curative resection: A longitudinal cohort study in Korea. Ann Surg. 256:1008–1013. 2012.PubMed/NCBI View Article : Google Scholar
45	Aahlin EK, Tranø G, Johns N, Horn A, Søreide JA, Fearon KC, Revhaug A and Lassen K: Health-related quality of life, cachexia and overall survival after major upper abdominal surgery: A prospective cohort study. Scand J Surg. 106:40–46. 2017.PubMed/NCBI View Article : Google Scholar
46	Kleinbaum DG, Kupper LL and Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods. Wiley, New York, NY, pp447-456, 1982.
47	Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, et al: Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 48:16–31. 2019.PubMed/NCBI View Article : Google Scholar